LIVERHCC-IRE

  • Research type

    Research Study

  • Full title

    Treatment of LIVER-limited HepatoCellular Carcinoma (HCC) in patients with preserved liver function by IRreversible Electroporation: A prospective, international, multi-centre cohort study.

  • IRAS ID

    361876

  • Contact name

    Ajith Siriwardena

  • Contact email

    ajith.siriwardena@mft.nhs.uk

  • Sponsor organisation

    Angiodynamics

  • Clinicaltrials.gov Identifier

    NCT07192731

  • Duration of Study in the UK

    3 years, 0 months, 1 days

  • Research summary

    Hepatocellular carcinoma (HCC) is the third leading cause of cancer related death globally. Treatment options include systemic therapy such as chemotherapy and regional therapy such as surgery. However only a minority of patients will be suitable for surgery. Ablation techniques have been developed for those patients who have a tumour or tumours that cannot be resected surgically or who are not fit enough to undergo a major operation. Multiple ablative techniques are available, irreversible electroporation (IRE) works by passing short intense electrical pulses between probes to destablise cell membranes leading to cell death. This is performed under general anaesthesia at the site of the liver tumour. IRE provides the benefit of avoiding the production of thermal energy that can important liver structures in close proximity to the tumour unlike other ablative techniques.
    Multiple safety and efficacy studies have been undertaken in IRE however the patient numbers remain small and hence the pathways into IRE are unclear. In addition, the proportion of tumours successfully eradicated by IRE is unclear. If IRE is to become an established treatment for HCC, its efficacy must be established.
    Thus, the aim of this study is to evaluate the efficacy of IRE for the treatment of HCC and to identify practical treatment pathways for this treatment. This will be the first, prospective, multi-centre evaluation of IRE in this setting.

  • REC name

    North West - Greater Manchester West Research Ethics Committee

  • REC reference

    26/NW/0006

  • Date of REC Opinion

    21 May 2026

  • REC opinion

    Further Information Favourable Opinion